SCHEMBL4012968

SCHEMBL4012968

CS(=O)(=O)c1cc(Cl)ccc1F

nearest known ligand 0.56

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
CCR2 P41597 9/20 0.56
ALPL P05186 2/20 0.44
ACLY P53396 1/20 0.42
CNR1 P21554 2/20 0.41
PTGS2 P35354 2/20 0.41
CNR2 P34972 1/20 0.41
TRPV4 Q9HBA0 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30762457 1.00 CCR2 (0.56) CCR2ALPLACLYCNR1PTGS2
SCHEMBL12560662 0.85 CCR2 (0.68) CCR2TRPV4L3MBTL1
SCHEMBL533050 0.80 TRPV4 (0.50) CCR2ALPLACLYCNR1TRPV4
SCHEMBL5097716 0.80 CCR2 (0.49) CCR2PTGS2
SCHEMBL11158206 0.80 ALPL (0.45) CCR2ALPLACLYCNR1TRPV4
SCHEMBL31239603 0.80 MCL1 (0.56) CCR2L3MBTL1
SCHEMBL4589791 0.80 MCL1 (0.56) CCR2L3MBTL1
SCHEMBL15352925 0.79 TRPV4 (0.46) CCR2ALPLACLYCNR1TRPV4
SCHEMBL31704457 0.78 SMN1; SMN2 (0.55) PTGS2
SCHEMBL1645034 0.78 CA1 (0.47) CCR2ALPLACLYCNR1PTGS2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101541751-A Quinoline compounds WYETH CORP (US) 2009-09-23 CN disclosed
EP-2074098-A2 QUINOLINE COMPOUNDS Wyeth (US) 2009-07-01 EP disclosed
EP-1963259-A2 SUBSTITUTED DIPHENYLETHERS, -AMINES, -SULFIDES AND -METHANES FOR THE TREATMENT OF RESPIRATORY DISEASE AstraZeneca AB (SE) 2008-09-03 EP disclosed
WO-2008049047-A2 QUINOLINE COMPOUNDS WYETH (US) 2008-04-24 WO disclosed
WO-2007068894-A2 SUBSTITUTED DIPHENYLETHERS, -AMINES, -SULFIDES AND -METHANES FOR THE TREATMENT OF RESPIRATORY DISEASE ASTRAZENECA AB (SE) 2007-06-21 WO disclosed